Skip to main content

Janelle Bradley

Conference Coverage
11/18/2024
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success...
11/18/2024
APP Institute Oncology
Conference Coverage
12/06/2021
The inclusion of trastuzumab-based therapy with chemotherapy was associated with improved survival outcomes compared with chemotherapy alone for the third-line treatment of metastatic breast cancer.
The inclusion of trastuzumab-based therapy with chemotherapy was associated with improved survival outcomes compared with chemotherapy alone for the third-line treatment of metastatic breast cancer.
The inclusion of...
12/06/2021
Journal of Clinical Pathways
Conference Coverage
06/03/2022
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive prostate cancer.
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive prostate cancer.
Study findings presented at the...
06/03/2022
Journal of Clinical Pathways
Conference Coverage
12/07/2021
Study findings show patients with metastatic breast cancer treated with ribociclib plus aromatase inhibitors or fulvestrant are not at higher risk for thromboembolic events.
Study findings show patients with metastatic breast cancer treated with ribociclib plus aromatase inhibitors or fulvestrant are not at higher risk for thromboembolic events.
Study findings show patients...
12/07/2021
Journal of Clinical Pathways
News
02/23/2022
Study findings confirm the long-term efficacy of autologous hematopoietic stem cell transplantation for treating MCL.
Study findings confirm the long-term efficacy of autologous hematopoietic stem cell transplantation for treating MCL.
Study findings confirm the...
02/23/2022
Journal of Clinical Pathways
News
04/01/2022
Study findings revealed that 90% of patients with metastatic NSCLC in The US Oncology Network received ≥1 biomarker test prior to first-line treatment, though
Study findings revealed that 90% of patients with metastatic NSCLC in The US Oncology Network received ≥1 biomarker test prior to first-line treatment, though
Study findings revealed that 90%...
04/01/2022
Journal of Clinical Pathways
Conference Coverage
03/25/2022
Nina Shah, MD, argues in favor of pomalidomide over carfilzomib for patients with MM at first relapse in the real-world setting at the 2022 Great Debates and Updates in Hematologic Malignancies meeting.
Nina Shah, MD, argues in favor of pomalidomide over carfilzomib for patients with MM at first relapse in the real-world setting at the 2022 Great Debates and Updates in Hematologic Malignancies meeting.
Nina Shah, MD, argues in favor...
03/25/2022
Oncology
Conference Coverage
09/29/2021
Winston Wong, PharmD, editor-in-chief of the Journal of Clinical Pathways, presented findings from the 2021 Oncology Clinical Pathways Benchmarking Survey.
Winston Wong, PharmD, editor-in-chief of the Journal of Clinical Pathways, presented findings from the 2021 Oncology Clinical Pathways Benchmarking Survey.
Winston Wong, PharmD,...
09/29/2021
Clinical Pathways
Conference Coverage
03/30/2022
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Oliver Sartor, MD, discussed the evolving treatment landscape for metastatic hormone-sensitive prostate cancer.
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Oliver Sartor, MD, discussed the evolving treatment landscape for metastatic hormone-sensitive prostate cancer.
In a presentation at the 2022...
03/30/2022
Oncology
NCCN Updates Clinical Practice Guideline for B-Cell Lymphomas
03/17/2021
The National Comprehensive Cancer Network update of these guidelines covers follicular lymphoma.
The National Comprehensive Cancer Network update of these guidelines covers follicular lymphoma.
The National Comprehensive...
03/17/2021
Journal of Clinical Pathways